• Service
  • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • CER
  • About
Subscribe

Our Services

Strategy Consulting

  • Market Entry Strategy
  • Regulatory Strategy
  • Clinical Strategy
  • China Localization Strategy
  • Hainan Urgent Use Pathway
  • Innovation Pathway
  • Fast Track Pathway
  • Digital Health Consulting

Registration Affairs

  • Pre-market Registration
  • Modification Registration
  • Renewal Registration
  • Request for Classification
  • Legal Agent Representation
  • NMPA Expert Panel Meeting
  • NMPA Supplemental Notice

Quality Assurance

  • Postmarket Surveillance Compliance (IFU, Label, GSP)
  • Adverse Event Reporting
  • Recall Handling
  • Periodic Risk Evaluation Report
  • Annual QMS Self-Inspection Report
  • NMPA Inspections & Mock-Audit
  • QMS Establishment/Audit/Remediation
  • QA Gap Analysis
  • Factory Audit
  • Unique Device Identifier

Device Testing

  • China Local Type Testing
  • Device Modification Compliance Testing
  • Biocompatibility Testing
  • EMC Testing

Clinical Research Organization (CRO)

  • Clinical Trials/Research
  • Real-World Study
  • China CER & MDR CER
  • Clinical Evaluation Feasibility Assessment

Customized Training

  • China Regulatory Training
  • China QMS Training
  • China GCP Training
  • China Localization Training
  • Periodic Regulatory Updates Training

Other Services

  • Translation
  • Patent & Trademark
  • Distributor Evaluation & Audit
  • KOL Interview/Consultation
  • Investment
  • Global regulatory services
  • Service
  • Resources
    • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • About
  • CER
  • Subscribe
  • CN
  • US
  • Home
  • News
  • Regulations & Guidelines

News


  • Moments
  • Regulations & Guidelines
  • Fast Track Update
  • QMS/PMS
  • Other News
  • NMPA Monthly Newsletter
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021

Review Time Of Submissions For Registration Completed And Transferred In January To June 2024

2024-08-23

Submission typeProduct classificationAverage review time (days)Average time of expert consultation (days)Average time of deficiency response (days)Total time (days)Product…

China NMPA Newsletter – July 2024

2024-08-22

Featured Articles NMPA Medical Device New Approvals in June 2024 In June 2024, NMPA approved 134 medical devices,…

NMPA Medical Device New Approvals In June 2024

2024-07-30

In June 2024, NMPA approved 134 medical devices, including 14 Class III imported products, 11 Class II imported…

China’s NMPA Approves 277 Innovative Medical Devices

2024-07-30

In recent years, China's NMPA has been continuously promoting the innovation and development of the medical device industry.…

China NMPA And NHC’s Announcement On The Temporary Importation And Use Management Requirements Of Urgently Needed Medical Devices By Medical Institutions

2024-07-19

On July 19, 2024, China NMPA published an announcement on imported medical devices. In this announcement, imported medical…

China NMPA Newsletter – June 2024

2024-07-15

  Featured Articles NMPA Medical Device New Approvals in May 2024 In May 2024, NMPA approved 265 medical…

NMPA Issues Draft Guidelines For Inspection Of Medical Device Clinical Trial Sites

2024-07-04

On June 14, 2024, China NMPA has released this new guideline. This guideline aims to enhance the management…

NMPA Medical Device New Approvals In May 2024

2024-07-04

In May 2024, NMPA approved 265 medical devices, including 40 Class III imported products, 27 Class II imported…

China NMPA Newsletter – May 2024

2024-06-11

  Featured Articles NMPA Medical Device New Approvals in April 2024 In April 2024, NMPA approved 292 medical…

Four Innovative Products Including Implantable Deep Brain Stimulation Electrode Lead Kit Approved By China NMPA

2024-06-11

On May 28, 2024, China NMPA approved the registration applications for four innovative products: the Implantable Deep Brain…

NMPA Medical Device New Approvals In April 2024

2024-06-03

In April 2024, NMPA approved 292 medical devices, including 37 Class III imported products, 30 Class II imported…

China NMPA Implements Revised Classification Catalog For In Vitro Diagnostic Reagents

2024-06-03

On May 21 2024, the China NMPA has announced the implementation of the revised Classification Catalog for In…
12345...81012...Next »
Twitter Linkedin
United States
Email: info@bradyknowsmedical.com
Phone: +86 18600392020
China
Beijing Office: Room 1501-1502, East Ocean Centre, No. 24 A, Jianguomenwai Avenue, Chaoyang District, Beijing, China
Shanghai Office: Lingang New Zone, China (Shanghai) Pilot Free Trade Zone
Hainan Office: Boao Lecheng pilot zone of international medical tourism, Qionghai City, Hainan Province
Email: info@bradyknowsmedical.com
Phone: +86 18600392020 +86 10 65155991

©2025 Bradynuoen Beijing PharmTech Co Ltd All Rights Reserved.

京ICP备15042665号-7